Macrolides resitance to streptococcus pneumonia
Conclusion: According to this study, clarithromycin resistance rate is 58.1% in strep pneumonia patients .which is significantly high. So use of clarithromycin should not be included in first line treatment regime of patients with pneumonia.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Umer, E., Ahmed, Z., Arsalan, S. A. Tags: Acute critical care Source Type: research
More News: Biaxin | Clarithromycin | Hospitals | Influenza | Laboratory Medicine | Outbreaks | Pneumonia | Respiratory Medicine | Study